Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2019
- Schlagwort
-
Vaccinia
MERS (Disease)
Ankara
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2019
- Urheber
- Beteiligte Personen und Organisationen
-
Sutter, Gerd
- URN
-
urn:nbn:de:bvb:19-247038
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Veit, Svenja
- Sutter, Gerd
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2019
Ähnliche Objekte (12)
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of recombinant modified vaccinia virus Ankara for delivery of Middle East respiratory syndrome coronavirus spike protein antigens
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Funktionale Analyse der Coronavirus-MHV-JHM-Glykoproteine in Vaccinia-Virus-Rekombinanten
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering immunomodulatory African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Expression and characterization of SARS-CoV-2 proteins using recombinant vaccinia virus MVA-T7pol
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of recombinant modified vaccinia virus Ankara for delivery of Middle East respiratory syndrome coronavirus spike protein antigens
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Funktionale Analyse der Coronavirus-MHV-JHM-Glykoproteine in Vaccinia-Virus-Rekombinanten
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering immunomodulatory African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Expression and characterization of SARS-CoV-2 proteins using recombinant vaccinia virus MVA-T7pol
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of recombinant modified vaccinia virus Ankara for delivery of Middle East respiratory syndrome coronavirus spike protein antigens
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Funktionale Analyse der Coronavirus-MHV-JHM-Glykoproteine in Vaccinia-Virus-Rekombinanten
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering immunomodulatory African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro